🕵️ CV Sciences, Inc. ($CVSI)
SEC insider & ownership activity, last 12 months · CIK 1510964 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (10 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Charlie E. Cheever III | 10 | value withheld pending verification | 0 | – | Aug 7, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Charlie E. Cheever III | 13.1% | 13G | Sep 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 6, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 7, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 7, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 7, 2025 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2025 | filing ↗ |
| Shareholder vote (5.07) | Mar 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2025 | filing ↗ |
| Material agreement (1.01) | Feb 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2025 | filing ↗ |